Rein Therapeutics, Inc. Public Float
Rein Therapeutics, Inc. (RNTX) had Public Float of $32.26 million as of 2025-06-30, per its 10-K/A filed 2026-04-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-27
- 2025-06-30: Entity Public Float $32.26M.
- 2024-06-28: Entity Public Float $54.08B.
- 2023-06-30: Entity Public Float $6.59B.
- 2022-06-30: Entity Public Float $19.14B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $32.26M 10-K/A · filed 2026-04-27 |
| 2024-06-28 | $54.08B 10-K/A · filed 2025-04-30 |
| 2023-06-30 | $6.59B 10-K/A · filed 2024-04-29 |
| 2022-06-30 | $19.14B 10-K/A · filed 2023-04-28 |
| 2021-06-30 | $91.64B 10-K · filed 2022-03-28 |
| 2020-06-30 | $36.63M 10-K · filed 2021-03-24 |
| 2019-06-28 | $20.01M 10-K · filed 2020-03-30 |
| 2018-06-29 | $40.75M 10-K · filed 2019-03-29 |
| 2017-06-30 | $61.59M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |